UBS Group AG - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 22 filers reported holding THE ONCOLOGY INSTITUTE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
UBS Group AG ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q2 2023$1,328
-83.0%
2,414
-79.1%
0.00%
Q1 2023$7,823
-23.0%
11,538
+87.3%
0.00%
Q4 2022$10,165
+45.2%
6,161
+289.0%
0.00%
Q3 2022$7,000
+133.3%
1,584
+208.8%
0.00%
Q2 2022$3,000
-83.3%
513
-72.4%
0.00%
Q4 2021$18,0001,8590.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2021
NameSharesValueWeighting ↓
Triatomic Management LP 517,479$853,8400.72%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC 104,400$1720.25%
Prosight Management, LP 275,561$454,6760.25%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,360,052$5,544,0860.12%
Redmile Group, LLC 1,583,158$2,612,2110.11%
Alpine Global Management, LLC 46,326$760.02%
Saba Capital Management, L.P. 174,513$287,9460.00%
FMR LLC 12,001,982$19,803,2700.00%
Leucadia National 192,452$317,5460.00%
BANK OF AMERICA CORP /DE/ 31,995$52,7920.00%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders